Cellebrite DI (CLBT) Equity Ratio (2020 - 2025)

Cellebrite DI's Equity Ratio history runs 6 years deep, the most recent figure standing at 0.52 for Q4 2025.

• In Q4 2025, Equity Ratio rose 6.02% year-over-year to 0.52; the TTM figure through Dec 2025 stood at 0.52 (up 6.02% YoY), while the FY2025 annual figure was 0.52, up 6.02% from the prior year.
• Equity Ratio was 0.52 for Q4 2025 at Cellebrite DI, down from 0.54 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.54 in Q3 2025 to a low of 0.22 in Q4 2021.
• Historically, Equity Ratio has averaged 0.23 across 5 years, with a median of 0.14 in 2022.
• The sharpest annual moves came in 2021 and 2025: Equity Ratio sank 223.28% in 2021, then surged 1114.53% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.22 in 2021, then soared by 184.85% to 0.18 in 2022, then tumbled by 64.95% to 0.06 in 2023, then jumped by 657.9% to 0.49 in 2024, then grew by 6.02% to 0.52 in 2025.
• The last three Equity Ratio figures came in at 0.52 (Q4 2025), 0.54 (Q3 2025), and 0.52 (Q2 2025), per Business Quant data.